First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

528 Reviews

Credit Rating - KYTHERA BIOPHARMACEUTICALS (EUROPE) LIMITED

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: KYTHERA BIOPHARMACEUTICALS (EUROPE) LIMITED, C/O Milsted Langdon Llp, 46-48 East Smithfield, London, E1W 1AW. The legal status is a Private Limited Company and the current status at the registry of companies is Dissolved. The last filed accounts are dated 31 December 2016. The company was incorporated on 22 January 2007.

The accounts next due date is 30 September 2018. There are no mortgages.

The above was based on public record information as at 21 January 2025 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 06060748
Date Incorporated: 22 January 2007
Date Latest Accounts: 31 December 2016
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 06060748
Annual Return: 22 January 2016
Registered Office: C/O Milsted Langdon Llp, 46-48 East Smithfield, London, E1W 1AW
SIC Code and Operations: 72110
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

KYTHERA BIOPHARMACEUTICALS (EUROPE) LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 31 January 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
15290712 KYTHERA LIMITED Active
15603896 KYTHERIUX LTD Active
09066407 KYTHING LTD Active - Proposal to Strike off
05480202 KYTHIRA I T LIMITED Active
08102936 KYTHNOS PROPERTIES LTD Active - Proposal to Strike off

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd